I would like to congratulate Elisabet De Los Pinos, President & CEO of Aura Biosciences and an ex-student of mine, on raising $3.7 million from experienced biotech investors in these tough markets. Aura Biosciences is a US/Spanish biotech company that is developing groundbreaking nanotechnology for the targeted delivery of drugs. Last December the company moved to the offices of Jazzya, my holding company.
Aura Biosciences developed Nanosmart, a technology that uses the advantage of viruses to cross the membrane and deliver drugs into the cells. Unlike other technologies, the Nanosmart structure is a hollow nanoparticle that resembles the viral shell but does not carry any viral genome making it a safe technology for the delivery of a wide array of drugs.
Follow Martin Varsavsky on Twitter: twitter.com/martinvars